C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2011
10/12/2011	EP2094683B1 Bicyclic compounds and use as antidiabetics
10/12/2011	EP1919906B1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
10/12/2011	EP1861391B1 Methods for preparing substituted sulfoxide compounds
10/12/2011	EP1761522B1 Compounds and methods for treating dyslipidemia
10/12/2011	EP1525884B1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN1702065B Fluorene-based compound and organic electroluminescent display device using the same
10/12/2011	CN102216291A Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
10/12/2011	CN102216290A Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/12/2011	CN102216289A Nicotinic acetylcholine receptor ligands and the uses thereof
10/12/2011	CN102216288A Pyridine derivative or its salt, pesticide containing it and process for its production
10/12/2011	CN102216287A Fungicide heterocyclyl-triazinyl-amino derivatives
10/12/2011	CN102216286A Substituted (pyridyl)-azinylamine derivatives as plant protection agents
10/12/2011	CN102216285A Tetrasubstituted pyridazine hedgehog pathway antagonists
10/12/2011	CN102216284A Method for preparing a non-hydratable crystal form
10/12/2011	CN102216283A Quinazoline derivatives as NK3 receptor antagonists
10/12/2011	CN102216276A Heteroaryls amide derivatives and their use as glucokinase activators
10/12/2011	CN102216273A Naphthylacetic acids used as crth2 antagonists or partial agonists
10/12/2011	CN102216270A Novel bis-amides as antimalarial agents
10/12/2011	CN102216268A Novel estrogen receptor ligands
10/12/2011	CN102214795A Organic light-emitting device
10/12/2011	CN102212062A Derivative of amino ester, salt thereof and using method
10/12/2011	CN102212058A Single composite medicament (chiral nitrogenous heterocyclic ester) and synthesis method thereof as well as application of chiral nitrogenous heterocyclic ester in preparing low-toxicity CB1 receptor inhibitor
10/12/2011	CN102212057A Carboxylic acid non-steroidal anti-inflammatory agent derivative and preparation method and application thereof
10/12/2011	CN102212056A Novel bicyclo-carbostyril compounds
10/12/2011	CN102212031A Preparation method of 2-substituted-4-(piperidylmethyl) pyridine
10/12/2011	CN102212030A Substituted tetrahydrocarbazole antifungal compounds and preparation method thereof
10/12/2011	CN101389613B Macrocyclic factor viia inhibitors useful as anticoagulants
10/12/2011	CN101296909B Pyrazine derivatives and use as pI3K inhibitors
10/12/2011	CN101258134B 2-(4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists
10/11/2011	US8034958 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
10/11/2011	US8034949 Pyrrolidine compound and a process for preparing the same
10/11/2011	US8034948 Method for resolving omeprazole salts
10/11/2011	US8034943 6-aminoisoquinoline compounds
10/11/2011	US8034936 Spirocyclic cyclohexane compounds useful to treat substance dependency
10/11/2011	US8034933 graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides
10/11/2011	US8034931 Process for producing substituted aminoquinazolinone derivative, intermediate therefor, and pest control agent
10/11/2011	US8034832 Gyrase inhibitors and uses thereof
10/11/2011	US8034818 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates
10/11/2011	US8034815 Imidazol-1-yl-(4-pyridin-2-yl-piperazin-1-yl)-methanethione; Critical Outcome Technologies' Iead compound (COTI); kinase inhibitor; anticarcinogenic agent; especially small cell lung cancer; cervical, ovarian, skin, prostate, breast, colorectal, head, neck, or kidney cancer, sarcoma, leukemia
10/11/2011	US8034814 Phthalazine derivatives with angiogenesis inhibiting activity
10/11/2011	US8034811 Hydroxamic acid esters and pharmaceutical use thereof
10/11/2011	US8034636 Hydrophilic chemiluminescent acridinium labeling reagents
10/11/2011	US8034621 Chemical sensors of zinc, nickel, and copper ions
10/11/2011	US8034558 Acridone derivatives as labels for fluorescence detection of target materials
10/11/2011	US8033981 Radioactive member and method of making
10/11/2011	CA2578066C Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
10/11/2011	CA2551909C Substituted azole derivatives, compositions, and methods of use
10/11/2011	CA2514191C Compound inhibiting dipeptidyl peptidase iv
10/11/2011	CA2504907C Indoles useful in the treatment of androgen-receptor related diseases
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2488584C Methods, mixtures, kits and compositions pertaining to analyte determination
10/11/2011	CA2368768C Preparation of quinoline-substituted carbonate and carbamate derivatives
10/10/2011	CA2793975A1 Antibacterial isoquinolin-3-ylurea derivatives
10/06/2011	WO2011123751A2 Heterocyclic compounds and their uses
10/06/2011	WO2011123678A2 Substituted benzo-pyrido-triazolo-diazepine compounds
10/06/2011	WO2011123674A1 Compounds for treating neurodegenerative diseases
10/06/2011	WO2011123654A1 Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists
10/06/2011	WO2011123232A1 Cgrp receptor antagonist
10/06/2011	WO2011123063A1 Aldehyde-imidazole polymers
10/06/2011	WO2011121629A1 Indolic derivatives and use thereof in medical field
10/06/2011	WO2011121555A1 Antibacterial isoquinolin-3-ylurea derivatives
10/06/2011	WO2011121548A1 Process for the preparation of dexlansoprazole
10/06/2011	WO2011121546A1 Salts of dexlansoprazole and their preparation
10/06/2011	WO2011121505A1 Cytokine inhibitors
10/06/2011	WO2011121366A1 Pyrazole p38 map kinase inhibitors
10/06/2011	WO2011121309A1 Phenyl sulfonyl derivatives and their use as histamine h3 antagonists
10/06/2011	WO2011121055A1 Pyridinyl derivatives comprising a cyanoguanidine or squaric acid moiety
10/06/2011	WO2011120626A1 Materials for organic electroluminescence devices
10/06/2011	WO2011120604A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion"
10/06/2011	WO2011120475A1 A method of manufacturing (s)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2- pyrimidinyl)methyl]sulfinyl]-1h-benzimidazole using a chiral complex with mandelic acid
10/06/2011	WO2011120133A1 Non-nucleoside reverse transcriptase inhibitors
10/06/2011	WO2011081280A3 Novel glucokinase activators and processes for the preparation thereof
10/06/2011	WO2011080255A3 Fungicidal hydroximoyl - tetrazole derivatives
10/06/2011	WO2011071849A3 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications
10/06/2011	WO2011059763A3 Dimeric smac mimetics
10/06/2011	WO2011035110A3 Treatment for oxidative stress and/or hypertension
10/06/2011	WO2010103279A8 Bis aromatic compounds for use as ltc4 synthase inhibitors
10/06/2011	US20110245506 Process for Manufacturing Substituted 5-Methoxymethylpyridine-2,3-Dicarboxylic Acid Derivatives
10/06/2011	US20110245505 Process for Manufacturing 5-Formyl-Pyridine-2,3-Dicarboxylic Acid Esters
10/06/2011	US20110245493 Delivery of drug amines through an inhalation route
10/06/2011	US20110245492 Novel allelic variant of cyp2c19 associated with drug metabolism
10/06/2011	US20110245353 Sweet flavor modifier
10/06/2011	US20110245296 Non-nucleoside reverse transcriptase inhibitors
10/06/2011	US20110245271 Triazole-substituted arylamides as p2x3 and p2x2/3 antagonists
10/06/2011	US20110245269 Inhibitors of Advanced Glycation End Products
10/06/2011	US20110245266 Pyridin-2-one compounds and their use as modulators of the dopamine d3 receptor
10/06/2011	US20110245260 Analogs of dehydrophenylahistins and their therapeutic use
10/06/2011	US20110245257 Heterocyclic compounds and their uses
10/06/2011	US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/06/2011	US20110245247 Novel small molecule potentiators of metabotropic glutamate receptors
10/06/2011	US20110245242 Heterocyclically Substituted Anilinopyrimides
10/06/2011	US20110245232 Novel small molecule potentiators of metabotropic glutamate receptors i
10/06/2011	US20110245231 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
10/06/2011	US20110245227 Pyridone gpr119 g protein-coupled receptor agonists
10/06/2011	US20110245226 Piperidinyl derivatives as modulators of chemokine receptor activity
10/06/2011	US20110245225 Quinazolinamide derivatives
10/06/2011	US20110245223 Heterocyclic compounds
10/06/2011	US20110245220 Compounds and compositions as modulators of gpr119 activity
10/06/2011	US20110245210 Thalidomide analogs

1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 1080